Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Carcinoma, Non-Small-Cell Lung × lorlatinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 12 INDUSTRY 10 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1 Ganglioneuroblastoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 31 Paclitaxel 26 Cisplatin 22 Radiotherapy 21 Docetaxel 16 Gemcitabine 12 Pemetrexed 11 Radiosurgery 9 Bevacizumab 8 Etoposide 7 Magnetic Resonance Spectroscopy 6 Erlotinib Hydrochloride 6 Gene Expression Profiling 5 Cetuximab 5 durvalumab 4 cediranib 4 Vinorelbine 4 Specimen Handling 4 Ramucirumab 4 Polymerase Chain Reaction 4 Amplified Fragment Length Polymorphism Analysis 4 Watchful Waiting 3 Taxes 3 Surgical Procedures, Operative 3 Radiotherapy, Conformal 3 Psychiatric Rehabilitation 3 Neoadjuvant Therapy 3 Chemotherapy, Adjuvant 3 sotorasib 2 selpercatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04127110 2024-11-05

ALKALINE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡